Clinical trial
Effect of Brief Acceptance and Commitment Therapy on Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer Through Modulation of Inflammatory and Angiogenic Biomarkers.
NCT07570368 is registered in ClinicalTrials.gov with Universitas Airlangga as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Brief Acceptance and Commitment Therapy on Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer Through Modulation of Inflammatory and Angiogenic Biomarkers.
- Lead sponsor
- Universitas Airlangga
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 28, 2026
- Completion date
- January 31, 2027
- Enrollment
- 54 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast neoplasm female, locally advanced breast cancer, locally advanced breast cancer (labc)